Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 265 of 314 found articles
 
 
  SunRISe-1: phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to bacillus Calmette–Guérin who are ineligible for or decline radical cystectomy
 
 
Title: SunRISe-1: phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to bacillus Calmette–Guérin who are ineligible for or decline radical cystectomy
Author: Van Der Heijden, M.S.
Cutie, C.
Hampras, S.
Indoria, C.
Stewart, R.
Acharya, M.
Stromberg, K.
Li, X.
Beeharry, N.
Maffeo, J.
Jacob, J.M.
Tsiatas, M.
Appeared in: European urology open science
Paging: Volume 33 () nr. S3 pages S389-S390
Year: 2021
Contents:
Publisher: European Association of Urology. Published by Elsevier B.V.
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 265 of 314 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands